Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis

European Urology · Published 2026-07-01 · DOI 10.1016/j.eururo.2026.07.013

Authors (36)

Amar U Kishan, Yilun Sun, Christopher C. Parker, Paul Sargos, Matthew Sydes, Sylvie Chabaud, Meryem Brihoum, Stephane Supiot, Igor Latorzeff, Stephane Guerif, Tahmineh Romero Kalbasi, Michael L. Steinberg, Luca F. Valle, Kekoa Taparra, Matthew J. Farrell, Jonathan E. Shoag, Jorge A. Garcia, Jason R. Brown, Matthew B. Rettig, Adam E. Singer, Nikita Baclig, Robert E. Reiter, Scott Eggener, Wayne Brisbane, Soumyajit Roy, Angela Y. Jia, Ting Martin Ma, Nicholas G. Nickols, Jason A. Efstathiou, James J. Dignam, Wendy F. Seiferheld, Alan Pollack, Howard M. Sandler, Paul L. Nguyen, Pascal Pommier, Daniel E. Spratt

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kishan, A., Sun, Y., Parker, C., et al. (2026). Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis. European Urology. https://doi.org/10.1016/j.eururo.2026.07.013

Related articles